⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AZN News
AstraZeneca PLC
Guide to Avoid Pitfalls in Primary Cell Procurement Released! Cloud-Clone Corp. Unveils Buying Guide for Novice Researchers to Boost Research Efficiency
accessnewswire.com
LLY
AZN
BMRN
As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
prnewswire.com
AZN
HYFT
ABSI
NVDA
CERT
The Quantum Sector Hits an Inflection Point: Federal Money, Real Milestones, and a Security Race Running in Parallel
prnewswire.com
GOOGL
IONQ
AZN
ARQQ
QBTS
ABSI
NVDA
IBM
RGTI
CERT
Global TROP-2 Targeted Therapy Market Set to Reach USD 3.29 Billion by 2031 with an 8.6% CAGR
globenewswire.com
GILD
AZN
PFE
MRK
BMY
BIIB
BNTX
Tumor Microenvironment Modulation Market to Hit USD 3.73 Billion by 2031 with a 7.4% CAGR - Key Trends and Insights
globenewswire.com
BMY
MRK
AZN
PFE
REGN
GILD
AMGN
BE
LLY
IOVA
NVS
Global Cancer Biologics Market Poised to Reach USD 189 Billion by 2035 with a CAGR of 8.9%
globenewswire.com
ABT
ABBV
AMGN
AZN
BNTX
BMY
LLY
GILD
JNJ
MRK
NVS
PFE
SNY
TAK
Non-Small Cell Lung Cancer Market Poised for Robust Expansion at a 6.6% CAGR Through 2036, Driven by Emerging Targeted and Immunotherapy Innovations | DelveInsight
prnewswire.com
PFE
ABBV
RMD
GSK
AZN
BNTX
INCY
IOVA
RGEN
MRK
LLY
IBIO
GILD
AMGN
JNJ
NVS
RIGL
BIIB
Summer Davos highlights 'China Opportunity 2.0' as new growth engine
prnewswire.com
MMM
AZN
Abbisko Therapeutics and AstraZeneca Enter a Strategic Collaboration to Conduct the Clinical Trial of Lumipodlin (ABSK043), a First-in-Class Oral PD-L1 Inhibitor, in Combination with TAGRISSO® for NSCLC
prnewswire.com
AZN
Global Smart Inhalers Market to Witness Robust CAGR Growth Through 2030, Driven by Technological Innovation and Digital Health
globenewswire.com
AZN
NVS
GSK